OKYO Pharma Ltd - רווח נקי למניה אחת בשנים עשר החודשים האחרונים OKYO

Historical price action on the GURU.Markets platform demonstrates the -39.10 metric, while the business relies on the expertise of Gary Jacob and his team, who skillfully manage costs and investor confidence. Costly trials and patent protection for application methods create a high barrier to entry. Ultimately, the success of OKYO Pharma Limited (OKYO) in combating dry eye depends on the confirmed efficacy of the OK-101 molecule.
פילוחי מדדים פיננסיים ומדדי שוק עבור OKYO Pharma Inc (OKYO)

This indicator measures the earnings per share (EPS) dynamics over a rolling year, reflecting the efficiency of business capitalization and net income growth rates relative to previous periods. By analyzing the EPS YoY TTM growth value, an investor assesses the ability of OKYO Pharma Limited (OKYO) to convert clinical trial successes and FDA regulatory approvals into actual financial results, which is critical for valuing the company ahead of potential M&A transactions.